发明名称 Compositions for the treatment or prophylaxis of viral infections
摘要 A compound of the general formula (III): wherein X is O, S, NH or CH2; Y is O, S or NH; Z is O, S or CH2; R1 is C1-8 alkyl, especially C1-6 alkyl, preferably n-alkyl, e.g., n-pentyl or n-hexyl; at least one of R2 and R3 is H—[R4—R5]n—R6—, in which: H—[R4—R5]n— comprises an oligopeptide, R4 being an amino acid and R5 being an amino acid selected from proline, alanine, hydroxyproline, dihydroxyproline, thiazolidinecarboxylic acid (thioproline), dehydroproline, pipecolic acid (L-homoproline), azetidinecarboxylic acid, aziridinecarboxylic acid, glycine, serine, valine, leucine, isoleucine and threonine, R6 is a neutral, non-polar amino acid moiety that is bonded to R5 by a peptide bond, and n is 1, 2, 3, 4 or 5; and the other of R3 and R2 is H—[R4—R5]n-R6— or H; or a pharmaceutically acceptable salt thereof.
申请公布号 US8912163(B2) 申请公布日期 2014.12.16
申请号 US201313971631 申请日期 2013.08.20
申请人 Katholieke Universiteit Leuven;Consejo Superior de Investigaciones Ceintificas 发明人 Balzarini Jan;Camarasa Maria Jose;Velazquez Sonsoles
分类号 C07H23/00;C07H19/24;C07K5/083;C07K9/00;A61K47/48 主分类号 C07H23/00
代理机构 Cooley LLP 代理人 Cooley LLP ;Elrifi Ivor R.;Erlacher Heidi A.
主权项 1. A method of treatment of viral infection with the Varicella Zoster virus, comprising administering to a human or non-human animal patient in need of such treatment an effective amount of a compound of formula (III):wherein X is O, S, NH or CH2; Y is O, S or NH; Z is O, S or CH2; R1 is C1-8 alkyl; at least one of R2 and R3 is H—[R4—R5]n—R6—, in which: H—[R4—R5]n— comprises an oligopeptide,R4 is an amino acid,R5 is an amino acid selected from the group consisting of proline, alanine, hydroxyproline, dihydroxyproline, thiazolidinecarboxylic acid (thioproline), dehydroproline, pipecolic acid (L-homoproline), azetidinecarboxylic acid, aziridinecarboxylic acid, glycine, serine, valine, leucine, isoleucine and threonine,R6 is a neutral, non-polar amino acid moiety that is bonded to R5 by a peptide bond, andn is 1, 2, 3, 4 or 5; and the other of R3 and R2 is H—[R4—R5]n—R6— or H;or a pharmaceutically acceptable salt thereof.
地址 Leuven BE